Your BMI will fall into one of four categories, which helps providers assess your metabolic risk: Underweight: Under 18.5 Normal weight: 18.524.9 Overweight: 2529.9 Obesity: 30 or higher While BMI doesnt tell the full story (it doesnt account for muscle mass or fat distribution, for instance), it remains the primary clinical benchmark for determining GLP-1 eligibility
This gives your stomach space for food
Weekly tracking of your weight and blood sugar (if applicable) allows you to catch changes early and address them proactively
This also shows that GLP-1 can significantly improve clinical indexes, reduce inflammatory indicators, improve liver fat deposition, and be effective in the treatment of fatty liver
However, this same mechanism is responsible for nausea, bloating, vomiting, and early satiety, especially when the body has not yet adapted to the drug
It's important to work with a healthcare professional or registered dietitian to determine appropriate portion sizes for your individual needs